KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Invested Capital (2016 - 2025)

Exact Sciences has reported Invested Capital over the past 16 years, most recently at $2.4 billion for Q4 2025.

  • Quarterly Invested Capital changed 0.05% to $2.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 billion through Dec 2025, changed 0.05% year-over-year, with the annual reading at $2.4 billion for FY2025, 0.05% changed from the prior year.
  • Invested Capital was $2.4 billion for Q4 2025 at Exact Sciences, down from $2.5 billion in the prior quarter.
  • Over five years, Invested Capital peaked at $3.6 billion in Q1 2021 and troughed at $2.4 billion in Q1 2025.
  • The 5-year median for Invested Capital is $3.2 billion (2023), against an average of $3.0 billion.
  • Year-over-year, Invested Capital soared 99.78% in 2021 and then fell 24.82% in 2024.
  • A 5-year view of Invested Capital shows it stood at $3.4 billion in 2021, then decreased by 10.17% to $3.0 billion in 2022, then grew by 5.0% to $3.2 billion in 2023, then fell by 24.82% to $2.4 billion in 2024, then dropped by 0.05% to $2.4 billion in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Invested Capital are $2.4 billion (Q4 2025), $2.5 billion (Q3 2025), and $2.5 billion (Q2 2025).